BetaShares Global Healthcare ETF - Currency Hedged (ASX: DRUG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
BetaShares Global Healthcare ETF - Currency Hedged Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
BetaShares Global Healthcare ETF - Currency Hedged (ASX: DRUG)
Latest News
ETFs
A defensive ASX ETF for a recessionary environment: experts
Share Market News
ETF provider VanEck to launch 4 new ASX ETFs
DRUG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Edward Sippel | Non-Executive Director | Mar 2021 |
No profile reported in annual report
|
| Mr Alex Vynokur | Executive Director | Sep 2009 |
Mr Vynokur is responsible for leading the strategy and overall management of the business. Alex was involved in the establishment and development of Australian financial services businesses including Pengana Capital and Centric Wealth. Alex is a director and principal of Apex Capital Partners. He is also a director of Toranotec Ltd. Alex previously worked at Turnbull Pillemer Capital, where he focussed on identifying and managing investments across the financial services industry. Prior to commencing his career in financial services, Alex was a lawyer at Baker & McKenzie, specialising in mergers and acquisitions and financial services.
|
| Mr Jason Gellert | Executive Director | Mar 2021 |
No profile reported in annual report
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| No Top 20 Shareholder | 0 | 0.00% |